Ganciclovir
- 5 September 1996
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 335 (10), 721-729
- https://doi.org/10.1056/nejm199609053351007
Abstract
Ganciclovir is a nucleoside analogue of guanosine, a homologue of acyclovir, and the first antiviral drug to be effective in the treatment of cytomegalovirus (CMV) disease in humans.14 It inhibits not only all the herpesviruses but also the transformation of normal cord-blood lymphocytes by Epstein–Barr virus.57 In this review, I outline ganciclovir's mechanisms of action and resistance and discuss the clinical effectiveness of intravenous and oral ganciclovir.Mechanism of ActionThe structures of ganciclovir and of its analogue acyclovir are shown in Figure 1. In vivo, ganciclovir is converted to ganciclovir triphosphate, which inhibits viral DNA polymerases, including those . . .Keywords
This publication has 83 references indexed in Scilit:
- Ganciclovir absolute bioavailability and steady-state pharmacokinetics after oral administration of two 3000-mg/d dosing regimens in human immunodeficiency virus— and cytomegalovirus-seropositive patientsClinical Therapeutics, 1995
- Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDSAIDS, 1995
- Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antiviralsClinical and Diagnostic Virology, 1993
- Concurrent Use of Ganciclovir and Foscarnet to Treat Cytomegalovirus Infection in AIDS PatientsThe Journal of Infectious Diseases, 1993
- Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus RetinitisNew England Journal of Medicine, 1992
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- Progressive Disease Due to Ganciclovir-Resistant Cytomegalovirus in Immunocompromised PatientsNew England Journal of Medicine, 1989
- Ganciclovir for Treatment of Renal Transplant-Associated Primary Cytomegalovirus PneumoniaThe Journal of Infectious Diseases, 1988
- Treatment of Serious Cytomegalovirus Infections with 9-(1,3-Dihydroxy-2-Propoxymethyl)Guanine in Patients with AIDS and Other ImmunodeficienciesNew England Journal of Medicine, 1986
- Activation by thymidine kinase and potent antiherpetic activity of 2′-nor-2′-deoxyguanosine (2′NDG)Biochemical and Biophysical Research Communications, 1982